Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$46.97 - $58.27 $993,462 - $1.23 Million
-21,151 Reduced 78.76%
5,705 $276,000
Q4 2022

Feb 14, 2023

SELL
$52.05 - $65.0 $4.08 Million - $5.09 Million
-78,374 Reduced 74.48%
26,856 $1.62 Million
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $1.11 Million - $2.67 Million
44,034 Added 71.96%
105,230 $6.38 Million
Q2 2022

Aug 15, 2022

SELL
$22.73 - $39.98 $590,002 - $1.04 Million
-25,957 Reduced 29.78%
61,196 $1.66 Million
Q1 2022

May 16, 2022

SELL
$30.27 - $49.22 $754,086 - $1.23 Million
-24,912 Reduced 22.23%
87,153 $3.19 Million
Q4 2021

Feb 14, 2022

BUY
$42.11 - $73.26 $3.32 Million - $5.77 Million
78,744 Added 236.32%
112,065 $5.54 Million
Q3 2021

Nov 15, 2021

BUY
$48.2 - $78.89 $627,853 - $1.03 Million
13,026 Added 64.18%
33,321 $2.37 Million
Q2 2021

Aug 16, 2021

SELL
$21.63 - $57.65 $843,634 - $2.25 Million
-39,003 Reduced 65.77%
20,295 $1.04 Million
Q1 2021

May 17, 2021

SELL
$11.0 - $28.24 $1.7 Million - $4.36 Million
-154,311 Reduced 72.24%
59,298 $1.49 Million
Q4 2020

Feb 16, 2021

SELL
$10.12 - $13.94 $818,293 - $1.13 Million
-80,859 Reduced 27.46%
213,609 $2.57 Million
Q3 2020

Nov 16, 2020

SELL
$9.93 - $13.47 $545,246 - $739,624
-54,909 Reduced 15.72%
294,468 $2.94 Million
Q2 2020

Aug 14, 2020

BUY
$9.56 - $12.51 $104,471 - $136,709
10,928 Added 3.23%
349,377 $3.66 Million
Q1 2020

May 15, 2020

SELL
$7.54 - $15.77 $46,469 - $97,190
-6,163 Reduced 1.79%
338,449 $3.62 Million
Q4 2019

Feb 14, 2020

SELL
$7.48 - $17.01 $68,778 - $156,406
-9,195 Reduced 2.6%
344,612 $5.46 Million
Q3 2019

Nov 14, 2019

SELL
$6.89 - $10.45 $512,774 - $777,720
-74,423 Reduced 17.38%
353,807 $2.77 Million
Q2 2019

Aug 14, 2019

SELL
$8.85 - $12.49 $801,553 - $1.13 Million
-90,571 Reduced 17.46%
428,230 $4.53 Million
Q1 2019

May 15, 2019

BUY
$10.32 - $14.49 $4.75 Million - $6.67 Million
460,223 Added 785.66%
518,801 $6.29 Million
Q4 2018

Feb 14, 2019

BUY
$8.73 - $13.74 $146,480 - $230,543
16,779 Added 40.14%
58,578 $603,000
Q3 2018

Nov 14, 2018

SELL
$12.7 - $15.79 $187,794 - $233,486
-14,787 Reduced 26.13%
41,799 $547,000
Q2 2018

Aug 14, 2018

SELL
$10.99 - $44.21 $69,874 - $281,087
-6,358 Reduced 10.1%
56,586 $825,000
Q1 2018

May 15, 2018

BUY
$27.95 - $45.04 $1.59 Million - $2.57 Million
57,044 Added 966.85%
62,944 $2.31 Million
Q4 2017

Feb 14, 2018

SELL
$35.44 - $63.76 $40,472 - $72,813
-1,142 Reduced 16.22%
5,900 $221,000
Q3 2017

Nov 14, 2017

BUY
$53.83 - $67.75 $379,070 - $477,095
7,042
7,042 $456,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $701M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.